Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
37281 | 62 | 17.1 | 33% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
351 | 3 | GAP JUNCTION//CONNEXIN//OLIGODENDROCYTE | 35607 |
3707 | 2 | PARALYSIS//MOXISYLYTE//MEMBRANE SEALING | 1088 |
37281 | 1 | MOXISYLYTE//ALPHA ADRENOCEPTOR BLOCKING AGENTS//CAS 964 52 3 | 62 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MOXISYLYTE | authKW | 2011082 | 11% | 58% | 7 |
2 | ALPHA ADRENOCEPTOR BLOCKING AGENTS | authKW | 1477534 | 5% | 100% | 3 |
3 | CAS 964 52 3 | authKW | 985023 | 3% | 100% | 2 |
4 | THYMOXAMINE | authKW | 716375 | 6% | 36% | 4 |
5 | CARLYTENE | authKW | 492511 | 2% | 100% | 1 |
6 | CARLYTENE TM | authKW | 492511 | 2% | 100% | 1 |
7 | CARLYTENER | authKW | 492511 | 2% | 100% | 1 |
8 | CAS 54 32 0 | authKW | 492511 | 2% | 100% | 1 |
9 | DEACETYLMOXISYLYTE SULPHOCONJUGATE | authKW | 492511 | 2% | 100% | 1 |
10 | DEACETYLTHYMOXAMINE | authKW | 492511 | 2% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1296 | 82% | 0% | 51 |
2 | Chemistry, Medicinal | 211 | 18% | 0% | 11 |
3 | Toxicology | 23 | 6% | 0% | 4 |
4 | Chemistry, Multidisciplinary | 15 | 13% | 0% | 8 |
5 | Medical Laboratory Technology | 4 | 2% | 0% | 1 |
6 | Chemistry, Analytical | 4 | 5% | 0% | 3 |
7 | Neurosciences | 3 | 6% | 0% | 4 |
8 | Obstetrics & Gynecology | 0 | 2% | 0% | 1 |
9 | Biochemical Research Methods | 0 | 2% | 0% | 1 |
10 | Physiology | 0 | 2% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHYSIOL BOX 31 450 CLARKSON AVE | 123126 | 2% | 25% | 1 |
2 | PHARMACOCINET | 4208 | 2% | 1% | 1 |
3 | PHARM | 5 | 3% | 0% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 11539 | 10% | 0% | 6 |
2 | JOURNAL DE PHARMACOLOGIE | 5877 | 3% | 1% | 2 |
3 | JOURNAL OF PHARMACOLOGICAL METHODS | 5721 | 5% | 0% | 3 |
4 | JOURNAL OF PHARMACY AND PHARMACOLOGY | 3945 | 13% | 0% | 8 |
5 | PHARMACOLOGICAL RESEARCH COMMUNICATIONS | 2156 | 3% | 0% | 2 |
6 | ACTA THERAPEUTICA | 1984 | 2% | 0% | 1 |
7 | ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE | 1961 | 5% | 0% | 3 |
8 | ARZNEIMITTELFORSCHUNG-DRUG RESEARCH | 1568 | 3% | 0% | 2 |
9 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1006 | 5% | 0% | 3 |
10 | JOURNAL OF AUTONOMIC PHARMACOLOGY | 585 | 2% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MOXISYLYTE | 2011082 | 11% | 58% | 7 | Search MOXISYLYTE | Search MOXISYLYTE |
2 | ALPHA ADRENOCEPTOR BLOCKING AGENTS | 1477534 | 5% | 100% | 3 | Search ALPHA+ADRENOCEPTOR+BLOCKING+AGENTS | Search ALPHA+ADRENOCEPTOR+BLOCKING+AGENTS |
3 | CAS 964 52 3 | 985023 | 3% | 100% | 2 | Search CAS+964+52+3 | Search CAS+964+52+3 |
4 | THYMOXAMINE | 716375 | 6% | 36% | 4 | Search THYMOXAMINE | Search THYMOXAMINE |
5 | CARLYTENE | 492511 | 2% | 100% | 1 | Search CARLYTENE | Search CARLYTENE |
6 | CARLYTENE TM | 492511 | 2% | 100% | 1 | Search CARLYTENE+TM | Search CARLYTENE+TM |
7 | CARLYTENER | 492511 | 2% | 100% | 1 | Search CARLYTENER | Search CARLYTENER |
8 | CAS 54 32 0 | 492511 | 2% | 100% | 1 | Search CAS+54+32+0 | Search CAS+54+32+0 |
9 | DEACETYLMOXISYLYTE SULPHOCONJUGATE | 492511 | 2% | 100% | 1 | Search DEACETYLMOXISYLYTE+SULPHOCONJUGATE | Search DEACETYLMOXISYLYTE+SULPHOCONJUGATE |
10 | DEACETYLTHYMOXAMINE | 492511 | 2% | 100% | 1 | Search DEACETYLTHYMOXAMINE | Search DEACETYLTHYMOXAMINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MARQUER, C , BRESSOLLE, F , (1997) HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC DETERMINATION OF THE CONJUGATE METABOLITES OF MOXISYLYTE IN HUMAN PLASMA AND URINE.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 691. ISSUE 2. P. 389-396 | 12 | 86% | 0 |
2 | NEAU, B , ROUX, J , LAMBREY, B , COURTIOL, C , MARTY, JP , GRISLAIN, L , (1995) METABOLISM OF C-14 MOXISYLYTE IN HAIRLESS RAT - COMPARISON BETWEEN INTRAVENOUS AND ORAL ROUTE.ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH. VOL. 45-1. ISSUE 1. P. 10-14 | 10 | 100% | 0 |
3 | MARQUER, C , BRESSOLLE, F , (1998) MOXISYLYTE: A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND ITS THERAPEUTIC USE IN IMPOTENCE.FUNDAMENTAL & CLINICAL PHARMACOLOGY. VOL. 12. ISSUE 4. P. 377 -387 | 16 | 50% | 10 |
4 | NEAU, B , ROUX, J , MARTY, JP , (1998) METABOLISM OF C-14-MOXISYLYTE AFTER PERCUTANEOUS APPLICATION IN HAIRLESS RAT.ARZNEIMITTELFORSCHUNG-DRUG RESEARCH. VOL. 48. ISSUE 1. P. 34-38 | 12 | 60% | 1 |
5 | COSTA, P , BRESSOLLE, F , BROMETPETIT, M , MOSSER, J , SARRAZIN, B , (1992) PHARMACOKINETICS OF MOXISYLYTE IN HEALTHY-VOLUNTEERS AFTER INTRAVENOUS AND ORAL-ADMINISTRATION.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 81. ISSUE 12. P. 1223-1226 | 8 | 80% | 2 |
6 | COSTA, P , BRESSOLLE, F , JARROUX, E , SARRAZIN, B , MOSSER, J , NAVRATIL, H , GALTIER, M , (1993) MULTIPLE-DOSE PHARMACOKINETICS OF MOXISYLYTE AFTER ORAL-ADMINISTRATION TO HEALTHY-VOLUNTEERS.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 82. ISSUE 9. P. 968-971 | 7 | 78% | 0 |
7 | COSTA, P , BRESSOLLE, F , MOTTET, N , ROUZIERPANIS, R , NAVRATIL, H , MARQUER, C , (1996) PHARMACOKINETICS OF MOXISYLYTE IN HEALTHY VOLUNTEERS AFTER INTRAVENOUS INFUSION AND INTRACAVERNOUS ADMINISTRATION WITH AND WITHOUT A PENILE TOURNIQUET.THERAPEUTIC DRUG MONITORING. VOL. 18. ISSUE 2. P. 135-144 | 11 | 42% | 3 |
8 | BRESSOLLE, F , COSTA, P , ROUZIERPANIS, R , MARQUER, C , (1996) PHARMACOKINETICS OF MOXISYLYTE IN HEALTHY VOLUNTEERS AFTER INTRACAVERNOUS INJECTION OF INCREASING DOSES.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 49. ISSUE 5. P. 411-415 | 7 | 58% | 1 |
9 | NEAU, B , ROUX, J , COURTIOL, C , LAMBREY, B , MARTY, JP , (1995) PHARMACOKINETICS STUDY OF C-14 MOXISYLYTE AFTER PERCUTANEOUS APPLICATION TO HAIRLESS RAT.ARZNEIMITTELFORSCHUNG-DRUG RESEARCH. VOL. 45-2. ISSUE 11. P. 1161-1165 | 8 | 50% | 0 |
10 | COSTA, P , BRESSOLLE, F , SARRAZIN, B , MOSSER, J , GALTIER, M , (1993) PHARMACOKINETICS OF MOXISYLYTE IN HEALTHY-VOLUNTEERS AFTER INTRAVENOUS AND INTRACAVERNOUS ADMINISTRATION.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 82. ISSUE 7. P. 729-733 | 8 | 50% | 2 |
Classes with closest relation at Level 1 |